Stockscreener 앱 받기
94.04
2.74%
2.4265
Corcept Therapeutics Inc 주식(CORT)의 최신 뉴스
Corcept Therapeutics highlights its endocrine focus as investors watch CORT stock - AD HOC NEWS
Corcept (CORT) executive sells 25K shares after exercising options - Stock Titan
CORTCorcept Therapeutics Inc Options - Finviz
Corcept Therapeutics stock hits 52-week high at 91.1 USD By Investing.com - Investing.com Canada
CORT Stock Skyrockets 35% After Early FDA Nod For Ovarian Cancer Drug - Stocktwits
CORT Stock Hits Highest Levels In 2026 – Cushing’s Syndrome Drug NDA Resubmission Extends 5-Session Rally - Stocktwits
CORT Stock Slips After-Hours On Weak Q4 Print: Retail Is Watching April FDA Meeting For Relacorilant As Next Catalyst - Stocktwits
Healthcare Stocks Investors Are Turning To After The Weak US Jobs Report - Sahm
Price to sales forward of Corcept Therapeutics Incorporated – NASDAQ:CORT - TradingView
Price to book forward of Corcept Therapeutics Incorporated – NASDAQ:CORT - TradingView
Enterprise value to revenue forward of Corcept Therapeutics Incorporated – NASDAQ:CORT - TradingView
Price to earnings forward of Corcept Therapeutics Incorporated – NASDAQ:CORT - TradingView
Corcept sinks after FDA rejects drug to treat hypertension - MSN
Corcept Therapeutics Incorporated(NasdaqCM:CORT) dropped from Russell 1000 Growth-Defensive Index - marketscreener.com
Corcept Therapeutics Incorporated(NasdaqCM:CORT) dropped from Russell 1000 Defensive Index - marketscreener.com
Corcept gives FDA new relacorilant data in resubmitted application - Cushing's Disease News
Kuehn Law Encourages Investors of Corcept Therapeutics Incorporated to Contact Law Firm - PR Newswire
Number of shareholders of Corcept Therapeutics Incorporated. – BX:HTD - TradingView
Corcept Therapeutics Incorporated. Actuals & Estimates (NASDAQ:CORT) - TradingView
HTD Forecast — Price Target — Prediction for 2027 - TradingView
Corcept Therapeutics Inc (CORT) Institutional Confidence - TradingKey
Corcept Therapeutics Inc (CORT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Corcept Therapeutics Inc (CORT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
CORT News | CORCEPT THERAPEUTICS INC (NASDAQ:CORT) - ChartMill
Corcept Therapeutics Inc (CORT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Corcept Therapeutics Inc (CORT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Corcept Therapeutics Inc (CORT) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Trust linked to Corcept (NASDAQ: CORT) director sells 10,000 shares in plan - Stock Titan
Corcept (CORT) director’s entities report 20K-share sale and large holdings - Stock Titan
Wolfe Research Upgrades Corcept Therapeutics (CORT) to Peer Perf - GuruFocus
Corcept Resubmits NDA for Relacorilant in Cushing's Syndrome - The Globe and Mail
symbol__ Stock Quote Price and Forecast - CNN
Corcept Therapeutics Inc (CORT) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Corcept Resubmits New Drug Application for Relacorilant as a Treatment for Patients with Cushing’s Syndrome - Business Wire
Corcept Therapeutics Inc (CORT) Valuation: PE, PB & Fair Value Analysis - TradingKey
Corcept Therapeutics (CORT) Resubmits NDA for Relacorilant with New Data - GuruFocus
Corcept Therapeutics (CORT) Resubmits Drug Application for Cushi - GuruFocus
Corcept Therapeutics (CORT) resubmits FDA NDA for relacorilant in Cushing’s syndrome - Stock Titan
Corcept Therapeutics(CORT.US) Officer Sells US$3.25 Million in Common Stock - Moomoo
Corcept Therapeutics (CORT) CFO exercises options, sells 40,000 shares in 10b5-1 trades - Stock Titan
Charles Schwab (NASDAQ: CORT) files Form 144 listing 20,000 shares - Stock Titan
[144] CORCEPT THERAPEUTICS INC SEC Filing - Stock Titan
Korlym improves results for diabetes patients taking GLP-1 drugs - Cushing's Disease News
Catalyst and Momentum Trials Data Fuels Optimism for Corcept Therapeutics (CORT) - Yahoo Finance
Norges Bank Purchases New Holdings in Corcept Therapeutics Incorporated $CORT - MarketBeat
Clearbridge Investments LLC Has $17.66 Million Position in Corcept Therapeutics Incorporated $CORT - MarketBeat
CORT to resubmit NDA for relacorilant in Cushing's syndrome, stock up - MSN
7 Health Care Stocks With Whale Alerts In Today's Session - Benzinga
1.60%
3.59%
자본화:
|
볼륨(24시간):